Reflects weighted average price. Range of prices were between $9.91 and $9.95. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Stock option vests 33 1/3% per year beginning on first anniversary of grant date.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever CryoLife makes a similar move, sign up!
Other recent filings from the company include the following:
President of CryoLife just disposed of 6,252 shares - March 10, 2014
CryoLife's Chief Accounting Officer just disposed of 521 shares - March 10, 2014
CryoLife's Vice President & Gen. Counsel just disposed of 1,217 shares - March 10, 2014
CryoLife's VP-Clinical Research just disposed of 869 shares - March 10, 2014
VP of CryoLife just disposed of 695 shares - March 10, 2014
CryoLife's VP Reg. Affrs. and Qual Assur. just disposed of 1,217 shares - March 10, 2014
Exec. VP of CryoLife just disposed of 1,739 shares - March 10, 2014
CryoLife's VP-Research and Development just disposed of 1,025 shares - March 10, 2014